GLP-1 Medications Could Be Game-Changer for Alcohol Use Disorder Treatment

Alcohol Use Disorder

The good news is that no matter how severe the problem may seem, most people with AUD can benefit from some form of treatment. Many others substantially reduce their drinking and report fewer alcohol-related problems. This guide is written for individuals—and their family and friends—who are looking for options to address alcohol problems. It is intended as a resource to understand what treatment choices are available and what to consider when selecting among them.

Alcohol Use Disorder

Related Clinical Trials

Many countries have adopted AUDIT as part of routine health assessments, helping to promote awareness and prevent the long-term consequences of excessive alcohol consumption. About 30% of people with alcohol use disorder are able to abstain from alcohol permanently without the help of formal treatment or a self-help program. Two of three people seeking treatment do reduce their intake and improve their overall health. Some people will go through periods where they remain sober, but then relapse.

How Is the AUDIT Scored?

  • But these may be easier for concerned family members and friends to ask, since they may hesitate to ask direct questions about quantity.
  • Among patients who smoke cigarettes, semaglutide also led to reductions in cigarette use.
  • If AUD is not treated, it can increase your risk for serious health problems.
  • Your health care provider or mental health provider will ask additional questions based on your responses, symptoms and needs.
  • Psychotherapy may help a person understand the influences that trigger drinking.
  • In an alcohol use disorder (AUD, commonly called alcoholism), excessive alcohol use causes symptoms affecting the body, thoughts and behavior.

People with this condition can’t stop drinking, even if their alcohol use upends their lives and the lives of those around them. While people with this condition may start drinking again, studies show that with treatment, most people are able to reduce how much they drink or stop drinking entirely. In this randomized clinical trial, relative to placebo, low-dose semaglutide reduced the amount of alcohol consumed during a posttreatment laboratory self-administration procedure. Common mental health conditions that co-occur with AUD are depressive disorders, anxiety disorders, trauma- and stress-related disorders, other substance use disorders, and sleep disorders. Studies show that people who have AUD are more likely to suffer from major depression or anxiety over their lifetime. When addressing drinking problems, it’s important to also seek treatment for any accompanying medical and mental health issues.

What is alcohol use disorder?

  • A health care provider can look at the number, pattern, and severity of symptoms to see whether AUD is present and help you decide the best course of action.
  • This means that when people with the disorder are abstaining from alcohol, they are still at increased risk of resuming unhealthy alcohol consumption, even if years have passed since their last drink.
  • However, since alcohol affects people in different ways, recognizing AUD in yourself or in others can be subjective and challenging.
  • Care is integrated with patients’ other health care to improve treatment access, reduce costs, and promote better physical and mental health outcomes.

This grade B recommendation can be accomplished using either the 1-item Single Alcohol Screening Question (SASQ) or the 3-item Alcohol Use Disorders Identification Test-Consumption. Unhealthy Alcohol Use in Adolescents and Adults] Those who screen positive should be evaluated for AUD using the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DMS-V) criteria. Medically managed withdrawal or detoxification can be safely carried out under medical guidance. Medications, such as benzodiazepines, are given to help control withdrawal symptoms. If necessary, patients may receive intravenous fluids, vitamins, and other medications to treat hallucinations or other symptoms caused by withdrawal.

  • Addiction medicine specialists at Rush can treat other mental health issues alongside alcohol use disorder.
  • If you’re concerned about someone who drinks too much, ask a professional experienced in alcohol treatment for advice on how to approach that person.
  • In more severe cases, people may also have seizures or hallucinations.
  • According to the Centers for Disease Control and Prevention (CDC), moderate drinking is typically defined as two drinks or fewer for men per day, or one drink or less for women.

It involved 48 patients with an average age of around 40, who all met the diagnostic criteria for alcohol use disorder but weren’t seeking treatment. The study’s participants received semaglutide weekly at increasing doses or a placebo. Researchers found that the semaglutide did not reduce the number of drinks per calendar day or the number of drinks participants chose to consume, but did have other benefits. Subcutaneous semaglutide was administered according to standard practice, with dose increases every 4 weeks. To maximize safety and feasibility, only the 2 lowest dose sequences (0.25 mg/week for weeks 1-4 and 0.5 mg/week for weeks 5-8) were used prior to primary outcome collection (between weeks 8 and 9). To obtain additional safety and prospective data, participants received a final dose increase (1.0 mg) at week 9, contingent on tolerability.

References and abstracts from MEDLINE/PubMed (National Library of Medicine)

Alcohol Use Disorder

Evidence that semaglutide showed minimal effects on proportion of drinking vs abstinence days—with the largest effect sizes observed for drinking quantity and heavy drinking—also has possible clinical implications. The potential for selective effects on quantitative reductions in drinking could render GLP-1RAs well suited to nonabstinence goals, which are a preferred treatment goal for many with AUD. Notably, laboratory self-administration results also suggested no medication effects on delay time or abstinence (eResults in Supplement 2). Studies with treatment-seeking samples are needed to determine whether GLP-1RAs can facilitate abstinence or prevent relapse. Models of weekly outcomes used intention-to-treat principles (all 48 randomized participants included).

These advances could optimize how treatment decisions are made in the future. Alcoholics AnonymousÂź (also known as “AA”) and other 12-step programs provide peer support for people quitting or cutting back on their drinking. Combined with treatment led by health care providers, mutual-support groups can offer a valuable added layer of support. This allows for a more precise evaluation of drinking patterns and helps determine whether a person is engaging in hazardous or excessive alcohol consumption.

Alcohol Use Disorder

Alcohol Use Disorder

The week 9 dose was treated as flexible and could be held at 0.5 mg or deferred for safety or practical reasons, based on physician judgement. Participants, investigators, and outcome assessors were blind to condition (see the eMethods in Supplement 2 for alcoholism treatment additional placebo and blinding information). This randomized clinical trial assesses the effects of subcutaneous semaglutide on alcohol consumption in adults with alcohol use disorder.

Similar articles

The criteria include having a pattern of consumption that leads to considerable impairment or distress. Alcohol dependence develops over time and can disrupt the balance of gamma-aminobutyric acid (GABA) in the brain and glutamate. GABA controls impulsiveness, while glutamate stimulates the nervous system. If you’re even a little concerned about behavior that feels why is alcoholism considered a chronic disease risky or out of control, we can help.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top